9-十四碳烯醛 | 60671-78-5

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: 9-十四碳烯醛
• 英文名称: 9-tetradecenal
• 英文别名: Tetradec-9-enal
• CAS: 60671-78-5
• 化学式: C₁₄H₂₆O
• 分子量: 210.36
• InChiKey: ANJAOCICJSRZSR-UHFFFAOYSA-N

物化性质

• 熔点：
  15°C (estimate)
• 沸点：
  299.9°C (estimate)
• 密度：
  0.8534 (estimate)
• LogP：
  5.599 (est)

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  15
• 可旋转键数：
  11
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.79
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2912190090

反应信息

• 作为产物：
  描述：

  Ethyl-tetradec-9-enoate 在 lithium aluminium tetrahydride 、 三氟乙酸吡啶 、 二甲基亚砜 、 N,N'-二环己基碳二亚胺 作用下， 生成 9-十四碳烯醛
  参考文献：
  名称：

  Preparation of pheromone components by cometathesis reactions in the presence of MoCl5/SiO2-R4Sn CATALYST

  摘要：

  DOI：

  10.1007/bf00962749

文献信息

• PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS
  申请人：PROVIVI, INC.

  公开号：US20170137365A1

  公开（公告）日：2017-05-18

  In one aspect, the invention provides a method for synthesizing a fatty olefin derivative. The method includes: a) contacting an olefin according to Formula I with a metathesis reaction partner according to Formula IIb in the presence of a metathesis catalyst under conditions sufficient to form a metathesis product according to Formula IIIb: and b) converting the metathesis product to the fatty olefin derivative. Each R 1 is independently selected from H, C 1-18 alkyl, and C 2-18 alkenyl; R 2b is C 1-8 alkyl; subscript y is an integer ranging from 0 to 17; and subscript z is an integer ranging from 0 to 17. In certain embodiments, the metathesis catalyst is a tungsten catalyst or a molybdenum catalyst. In various embodiments, the fatty olefin derivative is a pheromone. Pheromone compositions and methods of using them are also described.

  在一个方面，该发明提供了一种合成脂肪烯衍生物的方法。该方法包括：a）在存在一种烯烃催化剂的条件下，将符合式I的烯烃与符合式IIb的交换反应伙伴接触，以形成符合式IIIb的交换产物；并b）将交换产物转化为脂肪烯衍生物。每个R1独立地选择自H、C1-18烷基和C2-18烯基；R2为C1-8烷基；下标y为0至17之间的整数；下标z为0至17之间的整数。在某些实施方式中，交换催化剂为钨催化剂或钼催化剂。在各种实施方式中，脂肪烯衍生物为信息素。还描述了信息素组合物及其使用方法。
• AGRICULTURAL PHEROMONE COMPOSITIONS COMPRISING POSITIONAL ISOMERS
  申请人：PROVIVI, INC.

  公开号：US20170135343A1

  公开（公告）日：2017-05-18

  The present disclosure provides pheromone compositions. In some aspects, the compositions taught herein comprise a pheromone chemically corresponding to the pheromone naturally produced by a given insect, along with at least one positional isomer of said pheromone. In various aspects, pheromone compositions of the present disclosure are able to modulate the response of the insect based on the ratio of natural pheromone to its positional isomer.

  本公开提供信息素组合物。在某些方面，本文所教授的组合物包括一种与某种昆虫自然产生的信息素在化学上相对应的信息素，以及至少一种该信息素的位置异构体。在各个方面，本公开的信息素组合物能够通过自然信息素与其位置异构体的比例来调节昆虫的反应。
• Ether type lipid a 1-carboxylic acid analogs
  申请人：SANKYO COMPANY, LIMITED

  公开号：US20020161221A1

  公开（公告）日：2002-10-31

  A compound of formula (I) below, which exhibits excellent macrophage activity inhibitory action, is useful for the treatment or prophylaxis of inflammatory disorders, autoimmune diseases or septicemia. In a preferred embodiment, R 1 and R 3 each represents a C 1 -C 20 alkanoyl group which may optionally be substituted with one or more substituent groups selected from substituent group A, R 2 and R 4 each represents a C 1 -C 20 alkyl group which may optionally be substituted with one or more substituent groups selected from substituent group A, R 5 is a hydrogen atom, a halogen atom, a hydroxy group, or a C 1 -C 6 alkoxy group, and substituent group A is a halogen atom, a hydroxy group, an oxo group, a C 1 -C 20 alkoxy group, or a C 1 -C 20 alkanoyloxy group. 1

  以下为化合物式（I），该化合物表现出出色的巨噬细胞活性抑制作用，可用于治疗或预防炎症性疾病、自身免疫性疾病或败血症。在首选实施例中，R1和R3各代表一个C1-C20烷酰基团，该基团可以选择性地被一个或多个取代基团A所取代，R2和R4各代表一个C1-C20烷基团，该基团可以选择性地被一个或多个取代基团A所取代，R5是氢原子、卤素原子、羟基或C1-C6烷氧基团，取代基团A是卤素原子、羟基、氧代基、C1-C20烷氧基团或C1-C20烷酰氧基团。
• Glucosaminyl muramyl peptide derivatives
  申请人：Dainippon Pharmaceutical Co., Ltd.

  公开号：EP0094804A1

  公开（公告）日：1983-11-23

  Novel glucosaminyl muramyl peptide derivatives of the formula: wherein X is hydrogen atom or a group of the formula: R1CO-, Y is hydroxy group or a group of the formula: -OR2, or R, is an alkyl or alkenyl group, R2 is a lower alkyl group or a phenylalkyl group, R3 and r4 are the same or different and are each hydrogen atom or an alkyl group, Y' is hydroxy group or a group of the formula: -OR2 or (D) and (L) mean the configuration, provided that when X is hydrogen atom, Y is a group of the formula: or and their pharmaceutically acceptable salts. They have excellent biological activities such as potentiating activity of nonspecific resistance to microbial infections and immunostimulant activity and hence are useful in the prophylaxis and treatment of various microbial infections and the treatment of cancer in mammals.

  式中的新型葡糖胺基 muramyl 肽衍生物： 其中 X 是氢原子或式中的一个基团：R1CO-，Y 是羟基或式中的基团：-OR2、 或 R，是烷基或烯基，R2 是低级烷基或苯基烷基，R3 和 r4 相同或不同且各自是氢原子或烷基，Y' 是羟基或式中的基团：-OR2或 (D)和(L)指构型，条件是当 X 为氢原子时，Y 为式中的基团： 或 及其药学上可接受的盐类。它们具有优异的生物活性，如增强对微生物感染的非特异性抵抗活性和免疫刺激活性，因此可用于预防和治疗各种微生物感染以及治疗哺乳动物的癌症。
• Lupus assay method and compositions
  申请人：THE LIPOSOME CORPORATION

  公开号：EP0090735A2

  公开（公告）日：1983-10-05

  An assay for detecting SLE antibodies utilizing a novel liposome composition in which there is entrapped a divalent cation responsive indicator. The presence of such antibodies is detected by their stabilization of the supermolecular structure of the liposomes. Such stabilization can be detected, and in certain cases, caused by, the addition of magnesium or calcium ions.

  一种利用新型脂质体组合物检测系统性红斑狼疮抗体的检测方法，这种脂质体组合物中含有二价阳离子反应指示剂。这种抗体的存在是通过其对脂质体超分子结构的稳定作用来检测的。这种稳定作用可以通过添加镁离子或钙离子来检测，在某些情况下还可以通过添加镁离子或钙离子来实现。